Dylan Morris

Dylan Morris has a diverse range of work experience, primarily serving in board director roles for various companies in the biotechnology and healthcare industries. Dylan currently holds the position of Managing Director at Insight Partners. In addition, they are a Board Director for Profluent Bio, Unlearn.AI, ImmuneBridge, DEM Biopharma, Inc., Capacity Bio, Gameto, ArrePath, and Switch Therapeutics. Dylan also served as a Board Observer for NanoMosaic Inc. Their work experience spans from 2020 to the present, showcasing their extensive involvement and leadership in the industry.

Dylan Morris has pursued their education in the field of Biochemistry and Molecular Biophysics at Caltech, where they engaged in Graduate Research. Prior to that, they attended Harvard University, where they obtained an AB degree in Computer Science. The specific start and end years for both their educational experiences are not provided, thus further details are unknown.